Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr370.10 DKK
Change Today +13.00 / 3.64%
Volume 3.5M
As of 11:07 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mads Krogsgaard Thomsen Ph.D.

Chief Science Officer, Executive Vice President and Member of Executive Management,Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Mads Krogsgaard Thomsen, PhD serves as the Chief Science Officer and Executive Vice President at Novo Nordisk Canada Inc. Dr. Thomsen has been Chief Science Officer and Executive Vice President at Novo Nordisk A/S since November 2000 and serves as its Member of Executive Management. He is responsible for global research, development and regulatory affairs within Novo Nordisk. Dr. Thomsen joined Novo Nordisk in 1991 as head of Growth Hormone Research. He has been ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880


Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*



Unknown/Other Education 1986
Københavns Universitet
PhD 1989
Københavns Universitet
ScD 1991
Københavns Universitet

Other Affiliations*

Annual Compensation*

Total Annual Compensationkr8,100,000

Stock Options*

All Other Compensationkr2,300,000

Total Compensation*

Total Annual Cash Compensationkr10,400,000
Total Short Term Compensationkr8,100,000
Other Long Term Compensationkr2,300,000
Total Calculated Compensationkr10,400,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr370.10 DKK +13.00


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at